Optimer Pharma (OPTR) Names Stephen Webster as CFO
Tweet Send to a FriendGet Alerts OPTR Hot Sheet
Trade OPTR Now!
Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) has appointed Stephen Webster as Chief Financial Officer. Mr. Webster will be responsible for directing Optimer's financial strategy, accounting and investor relations functions.
Prior to joining Optimer, Mr. Webster served as Chief Financial Officer of Adolor Corporation until its sale to Cubist Pharmaceuticals, Inc.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Prior to joining Optimer, Mr. Webster served as Chief Financial Officer of Adolor Corporation until its sale to Cubist Pharmaceuticals, Inc.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- JPMorgan (JPM) Shareholders Support Dimon in Dual Role
- Otter Tail (OTTR) Director Olson Resigns
- Chesapeake Energy (CHK) Said to Tap Anadarko's (APC) Lawler as CEO
Create E-mail Alert Related Categories
Management ChangesRelated Entities
Cubist Pharmaceuticals Inc./Adolor Corp.
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
